Shira Yaari
Overview
Explore the profile of Shira Yaari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharman Moser S, Yaari S, Apter L, Poellinger B, Rheenen M, Arunachalam A, et al.
Cancer Epidemiol
. 2024 Oct;
93:102678.
PMID: 39357215
Introduction: We map the patient journey from symptom onset to intervention and describe primary treatment in a retrospective population-based cohort study of patients in a large healthcare-provider. Methods: Newly diagnosed...
2.
Sharman Moser S, Yaari S, Urban D, Apter L, Passwell N, Teper G, et al.
Cancer Epidemiol
. 2022 May;
79:102156.
PMID: 35594797
Background: Health-care providers in the US revealed that a substantial proportion of mNSCLC patients do not receive any first-line therapy and the biggest gaps in care are time inefficiencies in...
3.
Blum R, Elkon R, Yaari S, Zundelevich A, Jacob-Hirsch J, Rechavi G, et al.
Cancer Res
. 2007 Apr;
67(7):3320-8.
PMID: 17409441
Deregulation of Ras pathways results in complex abnormalities of multiple signaling cascades that contribute to human malignancies. Ras is therefore considered an appropriate target for cancer therapy. In light of...
4.
Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, Kloog Y
Clin Cancer Res
. 2005 Jun;
11(12):4321-30.
PMID: 15958613
Purpose: Our aim was to examine whether active Ras and MycN cooperation contributes to the malignant phenotype of human neuroblastoma with amplified MycN gene, an aggressive incurable tumor. Experimental Design:...